Answer
Increases in blood glucose have been reported in diabetic patients receiving Relvar Ellipta, and this should be considered when prescribing it to patients with a history of diabetes mellitus.
Sources for this answer
- Relvar Ellipta 184 micrograms/22 micrograms inhalation powder, pre-dispensedGlaxoSmithKline UK · emc · SmPC §4.4 Special warnings and precautions for use · Version 19Document updated
Sources checked